-
Symbol
-
CLLS on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Latest Disclosed Shares Owned
-
44,000,000 shares
-
Security Ownership %
-
44%
AstraZeneca PLC ownership in Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS)
24 Jan 2025 - AstraZeneca PLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 44,000,000 shares of Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS).
This represents 44% ownership of the company.
This is the first filing by ASTRAZENECA PLC disclosing ownership of Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS).